SYK
Stryker Corporation · Healthcare · Medical - Devices
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +13.6% ·
Aktienfluss -1.6% ·
neue Nettopositionen +8.0%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | +2 | 222.54M | $70.41B | +7 | −4 |
| Q1 2026 | 172 | -2 | 215.42M | $70.87B | +1 | −4 |
| Q4 2025 | 173 | -1 | 229.53M | $80.67B | +1 | −1 |
| Q3 2025 | 25 | +3 | 142.80M | $52.79B | +4 | −2 |
| Q2 2025 | 20 | 0 | 117.11M | $46.33B | +1 | −1 |
| Q1 2025 | 17 | -2 | 51.08M | $19.01B | — | −2 |
| Q4 2024 | 19 | 0 | 52.07M | $18.75B | +1 | −1 |
| Q3 2024 | 18 | +2 | 39.19M | $14.15B | +2 | — |
| Q2 2024 | 16 | — | 41.27M | $14.03B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 33.77M | +0.8% | $12.49B | 0.2% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passiv) | 26.73M | +0.4% | $9.88B | 0.2% | ▲ Add | 2 | SEC ↗ ×22 |
| 3 | JPMorgan Chase ✦ | 23.88M | — | $8.83B | 0.3% | n/c | 1 | SEC ↗ ×42 |
| 4 | State Street Global Advisors ✦ (passiv) | 14.94M | -0.1% | $5.54B | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 11.00M | -7.6% | $4.07B | 0.4% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (passiv) | 7.47M | +1.0% | $2.75B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 6.46M | — | $2.39B | 0.1% | n/c | 1 | SEC ↗ ×20 |
| 8 | Wellington Management ✦ | 5.29M | -4.8% | $1.96B | 0.3% | ▼ Trim | 6 | SEC ↗ ×8 |
| 9 | Fidelity (FMR) ✦ | 5.14M | -28.1% | $1.90B | 0.1% | ▼ Trim | 2 | SEC ↗ ×7 |
| 10 | Fisher Asset Management ✦ | 3.31M | -4.1% | $1.22B | 0.4% | ▼ Trim | 6 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 2.45M | — | $903.94M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 12 | Two Sigma Investments ✦ | 554.35K | +15.4% | $204.93M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 508.50K | +0.7% | $187.98M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 367.79K | Neu | $135.96M | 0.1% | New | 1 | SEC ↗ ×2 |
| 15 | Adage Capital Partners ✦ | 178.86K | -24.1% | $66.12M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 136.26K | +10.4% | $50.37M | 0.0% | ▲ Add | 6 | SEC ↗ ×6 |
| 17 | Millennium Management ✦ | 118.77K | +2617.8% | $43.90M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 116.65K | -71.9% | $43.12M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | Marshall Wace ✦ | 109.43K | +1819.8% | $40.45M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 20 | Renaissance Technologies ✦ | 103.20K | Neu | $38.15M | 0.1% | New | 1 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 94.47K | Neu | $34.92M | 0.1% | New | 1 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 22.47K | Neu | $8.31M | 0.0% | New | 1 | SEC ↗ |
| 23 | GAMCO Investors ✦ | 22.07K | -0.5% | $8.16M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 16.84K | +35.9% | $6.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Bridgewater Associates ✦ | 12.10K | +2.0% | $4.47M | 0.0% | ▲ Add | 6 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Citadel Advisors | $135.96M | 0.1% |
| Renaissance Technologies | $38.15M | 0.1% |
| Point72 Asset Management | $34.92M | 0.1% |
| Arrowstreet Capital | $8.31M | 0.0% |
Ausgestiegen
| Norges Bank | $1.88B | war 0.2% |
| Harris Associates (Oakmark) | $225,905 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 2,274 Inhaber, 283.44M Anteile, $87.41B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Director · 18 Ant. @ 225.19 · $4,054
Director · 3 Ant. @ 185.65 · $557
Director · 36 Ant. @ 193.21 · $6,956
Director · 11 Ant. @ 221.03 · $2,431
Director · 63 Ant. @ 202.21 · $12,739
Verkäufe auf dem offenen Markt (S)
Officer · 441 Ant. · $144,915
Director · 11.26K Ant. · $3.81M
Director · 40 Ant. · $13,272
Director · 440 Ant. · $146,598
Director · 200 Ant. · $66,786
Director · 80 Ant. · $26,804
Director · 320 Ant. · $107,774
Director · 2.31K Ant. · $780,062
Director · 10.81K Ant. · $3.67M
Director · 16.61K Ant. · $5.66M
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik